(Q73782135)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

N Ahluwalia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B S Skikne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

V Savin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Chonko

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

532-541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Iron status in patients receiving erythropoietin for dialysis-associated anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Assessing iron status in children with chronic renal failure on erythropoietin: which measurements should we use?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Relation of circulating red cell volume to body density and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

The Measurement of Total and Unsaturated Iron-Binding Capacity in Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

A serum ferritin assay for prevalence studies of iron deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Duodenal iron proteins in idiopathic hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Erythrocyte ferritin in patients on chronic hemodialysis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

New tools for clinical evaluation of erythron function in man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Iron deficiency and the measurement of iron status

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Thiazole orange: a new dye for reticulocyte analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Iron Absorption in Patients on Regular Dialysis Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Iron balance in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

Detection of functional iron deficiency during erythropoietin treatment: a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990313-9

7 January 2021

10.1016/S0272-6386(97)90313-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328369%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference